N-substituted glycine derivatives: hydroxylase inhibitors
US7608621B2 · kind B2 · utility
6Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 11, 2008 |
| Grant date | Oct 27, 2009 |
| Priority date | — |
| Expiry date | Jan 11, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention described herein relates to certain pyridazinedione N-substituted glycine derivatives of formula (I)which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.